AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,370.00
+70.00 (0.84%)
Apr 29, 2026, 1:20 PM KST

AptaBio Therapeutics Revenue

In the year 2025, AptaBio Therapeutics had annual revenue of 3.70B KRW with 10.02% growth. AptaBio Therapeutics had revenue of 1.00B in the quarter ending December 31, 2025, with 34.57% growth.

Revenue
3.70B
Revenue Growth
+10.02%
P/S Ratio
63.06
Revenue / Employee
n/a
Employees
n/a
Market Cap
233.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.70B336.93M10.02%
Dec 31, 20243.36B3.04B937.76%
Dec 31, 2023323.87M275.52M569.80%
Dec 31, 202248.35M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition